Related Experiment Video
Updated: Aug 12, 2026

Ex Vivo Organotypic Corneal Model of Acute Epithelial Herpes Simplex Virus Type I Infection
Published on: November 3, 2012
Oral acyclovir for the management of herpes simplex virus keratitis in children
1University of Minnesota, Department of Ophthalmology, Minneapolis, USA.
Insights
Oral acyclovir effectively treats herpes simplex virus (HSV) keratitis in children. This antiviral medication proved safe and beneficial for both acute infections and preventing recurrence in pediatric patients.
Area of Science:
- Ophthalmology
- Pediatric Infectious Diseases
- Virology
Background:
- Herpes simplex virus (HSV) keratitis is a significant cause of infectious corneal disease in children.
- Prompt and effective treatment is crucial to prevent vision-threatening complications.
Purpose of the Study:
- To assess the efficacy and safety of oral acyclovir for treating HSV infectious epithelial keratitis in pediatric patients.
- To evaluate the role of oral acyclovir in managing recurrent or complicated cases.
Main Methods:
- Retrospective case series of seven pediatric patients diagnosed with HSV infectious epithelial keratitis.
- Patients received oral acyclovir, with most also receiving topical antiviral therapy.
- Analysis of treatment outcomes, including resolution rates and adverse events.
Main Results:
- Complete resolution of HSV infectious epithelial keratitis was observed in all treated pediatric patients.
- Oral acyclovir was well-tolerated, with no reported adverse reactions.
- Prophylactic use of oral acyclovir was beneficial for patients with recurrent disease or those on topical corticosteroids for immune stromal keratitis.
Conclusions:
- Oral acyclovir demonstrates significant utility in treating HSV infectious epithelial keratitis in pediatric populations.
- The medication is effective for both acute treatment and prophylactic management, offering a safe therapeutic option.
Purpose:
To evaluate the use of oral acyclovir in pediatric patients with herpes simplex virus (HSV) keratitis.
Design:
Retrospective noncomparative case series.
Participants:
Seven pediatric patients seen at the University of Minnesota Hospitals and Clinics with herpes simplex virus (HSV) infectious epithelial keratitis between January 1992 and October 1998. Patient ages ranged from 6 weeks to 5 years at time of presentation with a median of 1.7 and mean of 1.9 years.
Intervention:
All patients received oral acyclovir; six of seven patients also received topical antiviral medications. Three of seven patients had topical antiviral therapy fail before being placed on oral acyclovir, and the remaining four patients were placed on oral acyclovir primarily.
Results:
All patients showed resolution of HSV infectious epithelial keratitis. Three patients have been maintained on prophylactic dosage of oral acyclovir because of recurrent disease or because they have been chronically treated with topical corticosteroids for immune stromal keratitis. All patients tolerated acyclovir well, and there were no adverse reactions.
Conclusions:
Oral acyclovir is useful in treating HSV infectious epithelial keratitis in pediatric patients. It is beneficial in treating infectious epithelial keratitis and prophylactically either while treating with topical corticosteroids for immune stromal keratitis or for preventing recurrent infectious epithelial keratitis.
Related Concept Videos
DNA Base Pairing
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Herpes
Chickenpox
Genital Herpes

